Mulatero Paolo, Bertello Chiara, Verhovez Andrea, Rossato Denis, Giraudo Giuseppe, Mengozzi Giulio, Limerutti Giorgio, Avenatti Eleonora, Tizzani Davide, Veglio Franco
Division of Internal Medicine and Hypertension, AOU San Giovanni Battista, Via Genova 3, 10126, Torino, Italy.
Curr Hypertens Rep. 2009 Jun;11(3):217-23. doi: 10.1007/s11906-009-0038-1.
Primary aldosteronism (PA) is the most frequent endocrine form of secondary hypertension. The recognition of this disease has dramatically increased with the widespread use of a screening test in most hypertensive patients, including those who are normokalemic. Interest in PA has grown since the demonstration that aldosterone has deleterious effects that are, at least in part, independent from its effects on blood pressure. The identification of the subtype of PA is fundamental to distinguish between subtypes that benefit from surgery and subtypes that should be treated pharmacologically with mineralocorticoid receptor antagonists. This article reviews the strategies to correctly identify PA subtypes, underlining the central role of adrenal vein sampling.
原发性醛固酮增多症(PA)是继发性高血压最常见的内分泌形式。随着在大多数高血压患者(包括血钾正常者)中广泛使用筛查试验,对这种疾病的认识已显著提高。自从有证据表明醛固酮具有有害作用,且至少部分作用独立于其对血压的影响以来,对PA的关注日益增加。确定PA的亚型对于区分受益于手术的亚型和应使用盐皮质激素受体拮抗剂进行药物治疗的亚型至关重要。本文综述了正确识别PA亚型的策略,强调了肾上腺静脉采血的核心作用。